Skip to content
Open access

Functional genomic characterization of anti-phage defense systems in vancomycin-resistant Enterococcus faecium

Nov 2026 · bioRxiv · 0 citations · 31 references
Biology

TL;DR

Genes predicted to cause resistance to bacteriophages, an adjunctive therapeutic approach for treating antibiotic-resistant bacterial infections, are identified and characterized among VREfm collected from infected patients.

Abstract

Vancomycin-resistant Enterococcus faecium (VREfm) is a significant public health threat, demonstrating high rates of antibiotic resistance and frequently causing hospital-acquired infections. Bacteriophages (phages) are a promising adjunctive therapy to reduce bacterial load and manage VREfm infections. Many bacteria encode anti-phage defense systems—groups of genes that can counteract phage infection—but these systems have not been characterized in VREfm. Here we explored the diversity of anti-phage defense systems within clinical VREfm isolate genomes and examined their impact on phage susceptibility. We first used two available bioinformatic tools (DefenseFinder and PADLOC) to identify putative anti-phage defense systems in 21 hybrid-assembled VREfm clinical isolate genomes, and observed that most anti-phage defense systems were located on plasmids, defense islands, and prophages. Combining this information with functional testing of phage susceptibility did not reveal robust associations between specific defense systems and resistance to four VREfm-targeting lytic phages. Due to inherent limitations of phage susceptibility testing, we next developed an assay to assess phage survival after co-incubation with bacteria, and identified over two dozen genes associated with phage killing, including a potentially novel defense island. Lastly, we attempted to functionally validate 10 candidate anti-phage defense systems, only four of which were ultimately tested in enterococci. Expression of one of these candidates, AbiE, decreased bacterial susceptibility to two Enterococcus-targeting phages. As VREfm- targeting phage therapy becomes more widely available, identification of genes contributing to phage resistance can aid in streamlining the provision of phages to patients who could benefit from this new therapeutic modality. IMPORTANCE VREfm is a significant public health threat, acquiring resistance to last-line antibiotics and becoming endemic in healthcare systems. There is a clear need for alternative therapies to treat VREfm infections. In this study we identified and characterized genes that are predicted to cause resistance to bacteriophages, an adjunctive therapeutic approach for treating antibiotic-resistant bacterial infections, among VREfm collected from infected patients. Our findings reveal a wide diversity of anti-phage defense systems in clinical VREfm isolates, and identify several possible drivers of phage resistance in this organism. The knowledge gained will inform the development of phage therapy for patients with difficult-to-treat VREfm infections.

Read PDF

Similar papers

Review Open access Sep 2026

Bacterial Defense and Phage Counterdefense: Unraveling the Molecular Basis of Phage Resistance

Phage therapy represents a promising strategy against multidrug-resistant bacteria, but its clinical effectiveness is increasingly compromised by the emergence of phage-resistant traits (PRTs). This resistance develops through multiple interconnected mechanisms that operate at different levels of bacterial defense. At...

Kunal Dutta, Kira M. Velieva, E. Skorb et al. · 0 citations
Open access Sep 2026

Phage genomes are enriched with genes to overcome diverse bacterial immune systems

It is demonstrated that a major portion of the phage genome is dedicated to counteracting ADSs, and 21 potential pairs of antiphage defense systems and phage-encoded anti-defense systems (ADSs) are identified.

Shinjiro Ojima, A. Azam, Kohei Kondo et al. · 0 citations
Review Open access Nov 2026

Enterobacteriaceae and Bacteriophages: Implications Against Antimicrobial Resistance.

Enterobacteriaceae represent a clinically challenging bacterial family owing to the global emergence of multidrug resistance. Bacteriophages, the natural predators of these bacteria, have emerged as powerful tools for detecting, targeting, and inhibiting these pathogens. This review provides a comprehensive overview of...

Ramya Ramadoss, Balasubramanian Moovarkumudalvan, Pradeep Jothimani et al. · 0 citations
Open access Sep 2026

Genomic Characterization of 30 Lytic Klebsiella pneumoniae Bacteriophages

A collection of candidate phages for further development as potential antimicrobial agents against CR-KP are described and the complexity in understanding phage–host dynamics of phages that recognize non-capsule receptors in K. pneumoniae is described.

Daniel Mora, Trisha Gryder, L. Lessor et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.